Patent · US Active

Expectorant compound, preparation method thereof and use thereof

US11993561B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2020
Grant dateMay 28, 2024
Priority date
Expiry dateApr 2, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure discloses an expectorant compound, and specifically discloses compounds represented by formula I and formula II, pharmaceutically acceptable salts or tautomers thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.